Diabetes and restenosis
Restenosis, defined as the re-narrowing of an arterial lumen after revascularization,
represents an increasingly important issue in clinical practice. Indeed, as the number of stent …
represents an increasingly important issue in clinical practice. Indeed, as the number of stent …
A systematic review and bioinformatic study on clinical, paraclinical, and genetic factors predisposing to stent restenosis following percutaneous coronary intervention
F Shahsanaei, A Gharibzadeh, S Behrooj… - BMC Cardiovascular …, 2024 - Springer
Background Stent restenosis is a relatively common phenomenon among patients with
coronary heart disease undergoing percutaneous coronary intervention (PCI). It seems that …
coronary heart disease undergoing percutaneous coronary intervention (PCI). It seems that …
Differential expression of miRNA-223 in coronary in-stent restenosis
S Ganjali, SH Aghaee-Bakhtiari, Ž Reiner… - Journal of Clinical …, 2022 - mdpi.com
Objective: In-stent restenosis (ISR) is an unfavorable complication that occurs in patients
after coronary stenting. Despite the progress with advent of modern DES and new …
after coronary stenting. Despite the progress with advent of modern DES and new …
Cerebrospinal fluid exosomal miR-152-3p predicts the occurrence of subarachnoid haemorrhage and regulates vascular smooth muscle cell dysfunction
Y Li, A Wu, W Dai, R Liu, B Jiang, R Zhou - Folia Neuropathologica, 2022 - termedia.pl
Results Compared with hydrocephalus, exosome miR-152-3p was lower in patients with
intracranial aneurysms, and among them, RA was lower than in patients with UA (p< 0.001) …
intracranial aneurysms, and among them, RA was lower than in patients with UA (p< 0.001) …
[HTML][HTML] 经皮冠状动脉介入治疗术后支架内再狭窄因素的探讨
马博博， 王晨霞 - Advances in Clinical Medicine, 2021 - hanspub.org
支架内再狭窄是冠心病介入治疗中面临的重大医学题, 也是研究的热点, 其主要发生机制尚不
清楚, 可能与平滑肌过度增生, 血管壁的重塑, 炎症反应等有关, 且其影响因素众多 …
清楚, 可能与平滑肌过度增生, 血管壁的重塑, 炎症反应等有关, 且其影响因素众多 …
Frequency of In-Stent Restenosis (ISR) in Diabetic Patients Following Percutaneous Coronary Intervention (PCI) for Stable Coronary Artery Disease (CAD) with …
AU Khan, F Akbar, S Ullah, H Zeb - Journal of Health and Rehabilitation …, 2024 - jhrlmc.com
Background: Coronary intervention with stenting is crucial for managing stable ischemic
heart disease and acute coronary syndrome, but post-procedural complications such as …
heart disease and acute coronary syndrome, but post-procedural complications such as …
Sensitivity of Plasma Micro RNAs as a Probable Non-Small Cell Lung Cancer Biomarker and its Significance
Z Sultan, Z Tufail, M Siddiqa - Journal of Pharmaceutical …, 2021 - eprints.go4mailburst.com
Non-small cell lung cancer (NSCLC) is the chief origin of death due to cancer. The
development of a less invasive diagnostic technique for NSCLC, especially at the beginning …
development of a less invasive diagnostic technique for NSCLC, especially at the beginning …
[PDF][PDF] Sensitivity of Plasma Micrornas as a Probable Non-Small Cell Lung Cancer Biomarker and Its Significance
QT ALI, MJ IQBAL, A MASOOD, A HUSSAIN… - pjmhsonline.com
Non-small cell lung cancer (NSCLC) is the chief origin of death due to cancer. The
development of a less invasive diagnostic technique for NSCLC, especially at the beginning …
development of a less invasive diagnostic technique for NSCLC, especially at the beginning …